Evidence map›Paper›PMID 38225874›Full record

ArticleSubstance use & misuse2024

Predictors of Suicidal Ideation and Continued Substance Use Problems Among Patients Receiving Methadone Maintenance Treatment Who Have Co-Occurring Cocaine Use Disorder.

Lourah M Kelly, Sheila M Alessi, Carla J Rash, Kristyn Zajac

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Substance use & misuse, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lourah M KellyUniversity of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-6955-3151
Sheila M AlessiUniversity of Connecticut School of Medicine, Farmington, CT, USA.ORCID 0000-0001-7254-7505
Carla J RashUniversity of Connecticut School of Medicine, Farmington, CT, USA.ORCID 0000-0001-9264-6885
Kristyn ZajacUniversity of Connecticut School of Medicine, Farmington, CT, USA.ORCID 0000-0002-1516-365X
University of Connecticut · US

Funding

TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1994 to 2018
$40.5M
ZONISAMIDE VERSUS PLACEBOM01RR006192 · NCRR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DRAZINIC, CAROLYN M · 1994 to 2008
$22.1M
Vulnerabilities for coping-related drinking among post-college young adultsP60AA003510 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HESSELBROCK, VICTOR M · 2008 to 2017
$17.5M
VOUCHERS VS PRIZES--CONTINGENCY MANAGEMENTR01DA013444 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE · 2000 to 2015
$6.2M
Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging AdultsR01DA051671 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Kristyn Zajac · 2021 to 2026
$3.5M
POST-DOCTORAL TRAINING PROGRAM IN ALCOHOL STUDIEST32AA007290 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI SHEILA MARIE ALESSI · 1985 to 2026
$3.2M
Training Therapists to Administer Contingency ManagementR01DA016855 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PETRY, NANCY M · 2003 to 2007
$1.8M
Development and Evaluation of an Avatar Guided Mobile Health for Emerging AdultsR00AA029154 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KELLY, LOURAH MARIE · 2023 to 2025
$747k
Development and evaluation of an avatar-guided mobile health intervention for emerging adults with alcohol misuse and suicidalityK99AA029154 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KELLY, LOURAH MARIE · 2022 to 2023
$384k
NCRR NIH HHS M01 RR006192NIAAA NIH HHS K99 AA029154NIAAA NIH HHS P60 AA003510NIAAA NIH HHS R00 AA029154NIAAA NIH HHS T32 AA007290NIDA NIH HHS P50 DA009241NIDA NIH HHS R01 DA013444NIDA NIH HHS R01 DA016855NIDA NIH HHS R01 DA051671
6 · The paper itself

Abstract

backgroundPersons with polysubstance use problems are at high suicide risk, which may complicate substance use treatment. The purpose of this study was to a) examine cross-sectional and longitudinal risk factors for suicidality among persons in methadone maintenance treatment who present with co-occurring cocaine use disorder and b) evaluate whether suicidality impacts substance use outcomes independently and differentially depending on treatment type (i.e. standard methadone care [SC] vs. contingency management plus standard care [CM + SC]).

methodsData come from five randomized controlled trials of CM conducted within methadone clinics (

resultsSuicidality groups differed by sex and baseline employment, income, trauma history, and psychosocial functioning. Suicide attempt history was positively associated with years of polysubstance use, prior drug treatments, and unintentional overdose history. Baseline psychological problem severity and emotional abuse history were associated with SI likelihood 12 weeks later. Past SI was associated with longer durations of abstinence than no suicidality. Unexpectedly, those with recent SI reported lower drug use severity at 12 week if they received SC compared to CM + SC. Effects were small to medium.

conclusionsDespite greater polysubstance use history, patients with suicide attempts did not show worse substance use outcomes than persons without suicidality. Patients with past SI fared

Indexed as

CocaineSubstance-Related DisordersCross-Sectional StudiesHumansMethadoneRisk FactorsSuicidal IdeationCocaineMethadonecocaine use disorderMethadone treatmentopioid use disordersuicidal ideationsuicide attempt

Identifiers

PMID38225874
PMCPMC10962756
OpenAlexW4390915506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.